Ben Caljon

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

Johnny Duerinck, Julia Katharina Schwarze, Gil Awada et al. · Journal for ImmunoTherapy of Cancer · 2021 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Rajendra Bahadur Shahi, Sylvia De Brakeleer, Ben Caljon et al. · BMC Cancer · 2019 · 51 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates

Robin Vanstokstraeten, Denis Piérard, Florence Crombé et al. · Scientific Reports · 2023 · 47 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Characteristics of Shiga toxin producing- and enteropathogenic Escherichia coli of the emerging serotype O80:H2 isolated from humans and diarrhoeic calves in Belgium

Klara De Rauw, Damien Thiry, Ben Caljon et al. · Clinical Microbiology and Infection · 2018 · 30 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma

Johnny Duerinck, Louise Lescrauwaet, Iris Dirven et al. · Neuro-Oncology · 2024 · 27 citations · Full text

Medicine, Neurosurgery, Oncology +17